Stock Information

• Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain?
  Thu, Jun 18, 2026 4:47 PM
• ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
  Thu, Jun 18, 2026 10:36 AM
• Penumbra wins CE mark for Thunderbolt clot removal tech
  Thu, Jun 18, 2026 10:00 AM
• Medtech M&A maintains momentum following decade-high 2025: PwC
  Wed, Jun 17, 2026 11:00 AM
• Penumbra’s Thunderbolt approval poised to accelerate neuro thrombectomy innovation
  Tue, Jun 16, 2026 4:27 PM
• Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
  Mon, Jun 15, 2026 1:00 PM
• Boston Scientific Eyes Neurovascular Growth With Penumbra Thunderbolt Clearance
  Sat, Jun 13, 2026 7:17 AM
• FDA clears Penumbra’s Thunderbolt thrombectomy platform for stroke
  Fri, Jun 12, 2026 3:34 PM
• Penumbra's Thunderbolt Device Offers Revenue Upside Not Reflected in Estimates, RBC Says
  Fri, Jun 12, 2026 2:52 PM
• Penumbra’s FDA nod for clot removal tech a win for Boston Scientific
  Fri, Jun 12, 2026 11:22 AM

Financial data not available